Torch Capital
VC Fund
New York, United States
Torch Capital is an early-stage venture fund investing in consumer technology companies and the infrastructure layers that power them
- Total investments:
- 148
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Torch Capital invests in
Stages Torch Capital invests in
Countries Torch Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2.5M–$14M
- Series A
- $8.5M–$25M
- Series B
- $12M–$85M
Investment Focus
Industry
- Financial Services 18 (12%)
- Health Care 16 (11%)
- Software 14 (9%)
- Information Technology 14 (9%)
- FinTech 13 (9%)
Stage
- Seed 56 (38%)
- Series A 29 (20%)
- Series B 10 (7%)
- Pre-Seed 9 (6%)
- Funding Round 6 (4%)
Country
- United States 68 (46%)
- United Kingdom 6 (4%)
- Canada 2 (1%)
- Spain 1 (1%)
- Germany 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Christopher Harper
Principal
|
Principal | Total investments: 3 | Find email | |
Curtis Cheng
Investor
|
Investor | Total investments: 3 | Find email | |
Jon Keidan
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 72 | Find email | |
Katie Reiner
Principal
|
Principal | Total investments: 10 | Find email | |
Sam Jones
Partner
|
Partner | Total investments: 1 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
F2 AI
|
F2 AI offers an AI platform specifically designed for private markets, including private finance, private equity, and commercial banking. | $14M / Seed / Jun 10, 2026 | |
Solace
|
Solace is a digital health platform that connects patients with expert healthcare advocates. Their health advocates are former doctors, nurses, pharmacists, and other clinical and experience-driven professionals who navigate patients through healthcare challenges. | $130M / Series C / Feb 10, 2026 | |
Salvo Health
|
Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $8.5M / Series A / Jan 22, 2026 | |
|
Salvo Health
|
Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $8.5M / Series A / Jan 22, 2026 | |
Asset
|
Asset helps platforms to slove accounting for their SMB customers. | Seed / Jan 01, 2026 | |
Howtoo
|
Howtoo is an online learning platform designed to provide instructional content for vehicle repair and upgrades. | Seed / Jan 01, 2026 | |
Obi Health
|
Obi Health is a US-based fertility technology company operating both a virtual fertility clinic and a platform connecting patients to fertility clinics nationwide. Obi coordinates with local OBGYN offices to handle the routine monitoring — blood draws and ultrasounds — that IVF cycles require, reducing the travel and time burden of treatment. Thecompany serves patients seeking fertility care across the US, offering full-cycle support, transparent pricing, and insurance acceptance. | Seed / Jan 01, 2026 | |
HeyAlfie
|
Hey Alfie is an AI-powered home management platform that helps users fix issues, get guidance, and book trusted local tradespeople. | Seed / Jan 01, 2026 | |
Ontime
|
Ontime is a fintech platform that enables users to pay their bills directly from their salary automatically on payday. | Seed / Jan 01, 2026 | |
Noble
|
Noble offers a platform that connects prospects with existing customer advocates via website widgets and Salesloft integration. | Seed / Jan 01, 2026 | |
| See all 148 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Torch Capital invest in?
Torch Capital invests primarily in Financial Services, Health Care and Software startups, most often at Seed and Series A stage. Most of the 148 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Torch Capital's check size?
Torch Capital typically joins rounds of $2.5M–$14M at Seed, $8.5M–$25M at Series A and $12M–$85M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Torch Capital participates in.
How do I contact Torch Capital?
Public channels for Torch Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Torch Capital?
The team at Torch Capital includes Christopher Harper (Principal), Curtis Cheng (Investor) and Jon Keidan (Founder & Managing Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
